The Notice of CFDA on Matters Related to the Adjustment of the Registration Administration of Imported Drugs was issued on Oct.10, 2017. It aims to encourage new drugs to be marketed and meet clinical needs, which includes relevant policies, regulations, and measures.
- Local Title:国家食品药品监督管理总局关于调整进口药品注册管理有关事项的决定
- Country/Region:Chinese Mainland
- Competent Authority: Former China Food and Drug Administration (CFDA)
- Type:Notice
- Status:In force
- Release Date:2017-10-10
- Implementation Date:2017-10-10